Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 204.20
-3.80 (-1.83%)
Jul 9, 2026, 4:08 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 18.47 billion as of July 9, 2026. Its market cap has decreased by -19.64% in one year.
Market Cap
18.47B
Enterprise Value
14.87B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
204.20
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 18.47B, an increase of 5.43%. That is a compound annual growth rate of 4.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 18.47B | -30.75% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 33.23B |
| Genscript Biotech | 29.04B |
| InnoCare Pharma | 28.14B |
| Keymed Biosciences | 24.73B |
| Zai Lab | 17.40B |
| Metis TechBio | 14.67B |
| Shaanxi Micot Pharmaceutical Technology | 13.63B |
| Ascentage Pharma Group International | 12.81B |